Citadel Advisors
LFST icon

Citadel Advisors’s Lifestance Health LFST Stock Holding History

Citadel Advisors’s Portfolio LFST Stock Details LFST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,900
Closed -$76.7K – 13666
2025
Q4 		$76.7K Sell
10,900
-82,900
-88% -$500K ﹤0.01% 11823
2025
Q3 		$516K Sell
93,800
-102,400
-52% -$502K ﹤0.01% 9059
2025
Q2 		$1.01M Sell
196,200
-257,100
-57% -$1.54M ﹤0.01% 7053
2025
Q1 		$3.02M Buy
453,300
+295,200
+187% +$2.24M ﹤0.01% 4757
2024
Q4 		$1.17M Sell
158,100
-14,900
-9% -$107K ﹤0.01% 6707
2024
Q3 		$1.21M Buy
173,000
+76,300
+79% +$459K ﹤0.01% 6471
2024
Q2 		$475K Buy
96,700
+47,800
+98% +$288K ﹤0.01% 8156
2024
Q1 		$302K Buy
48,900
+24,000
+96% +$162K ﹤0.01% 9442
2023
Q4 		$195K Buy
24,900
+8,300
+50% +$53.5K ﹤0.01% 9999
2023
Q3 		$114K Buy
16,600
+9,800
+144% +$79.4K ﹤0.01% 10719
2023
Q2 		$62.1K Sell
6,800
-4,500
-40% -$37.4K ﹤0.01% 11541
2023
Q1 		$84K Sell
11,300
-1,700
-13% -$9.43K ﹤0.01% 11500
2022
Q4 		$64.2K Sell
13,000
-9,300
-42% -$57.5K ﹤0.01% 11821
2022
Q3 		$148K Sell
22,300
-1,500
-6% -$10.5K ﹤0.01% 10715
2022
Q2 		$132K Buy
23,800
+10,300
+76% +$78.9K ﹤0.01% 11111
2022
Q1 		$136K Sell
13,500
-4,600
-25% -$40.4K ﹤0.01% 11960
2021
Q4 		$172K Sell
18,100
-3,700
-17% -$39.2K ﹤0.01% 12078
2021
Q3 		$316K Buy
+21,800
New +$420K ﹤0.01% 10958

Other funds holding LFST

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SP
Summit Partners Boston, Massachusetts $609M AUM 7.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SPIG
Silversmith Partners I GP Boston, Massachusetts $39.2M AUM
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Citadel Advisors's LFST Position: Q1 2026 in Review

Citadel Advisors increased its Lifestance Health (LFST) stake by 9,568% in Q1 2026, buying an estimated $26.5M and bringing the position to 3,850,026 shares worth $24.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2087.

Citadel Advisors first reported a position in LFST in Q2 2021 and has held it in 19 quarters since. 229 funds tracked by Wall St. Rank hold LFST as of Q1 2026.

  • Citadel Advisors held 3,850,026 shares of Lifestance Health worth $24.5M as of Q1 2026.
  • Citadel Advisors bought 3,810,205 Lifestance Health shares in Q1 2026, an estimated $26.5M.
  • Lifestance Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2087 holding.
  • Citadel Advisors first reported a position in Lifestance Health in Q2 2021 and has held it in 19 quarters since.
  • 229 funds tracked by Wall St. Rank held Lifestance Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.